An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 7.2025 1.00 09/10/2025 - 12:00am to 09/10/2026 - 12:00am
Recorded Presentation from Optimizing Patient Outcomes - Transitioning CAR T-Cell and Bispecific Therapies to the Outpatient Setting 1.00 09/30/2025 - 12:00am to 09/22/2026 - 12:00am
NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation 1.00 09/30/2025 - 12:00am to 04/19/2026 - 12:00am
Archived NCCN Tumor Boards: Exploring Omission of Radiation Therapy in the Management of Rectal Cancer 1.00 09/30/2025 - 12:00am to 09/16/2026 - 11:59pm
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 3.2025 1.00 10/10/2025 - 12:00am to 10/10/2026 - 11:59pm
Prostate Cancer Management Simulator 10/14/2025 - 12:00am to 10/13/2026 - 11:59pm
Archived NCCN Tumor Boards: Optimal Treatment Strategies for Metastatic Breast Cancer 1.00 10/29/2025 - 12:00am to 10/15/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - The Role of Immunotherapy and Emerging Strategies for High-Risk Neuroblastoma 1.00 11/05/2025 - 12:00am to 10/29/2026 - 11:59pm
NCCN Guidelines® Insights - Breast Cancer, Version 5.2025 1.00 11/10/2025 - 12:00am to 11/10/2026 - 11:59pm
NCCN Tumor Boards: Optimizing Treatment of Chronic Phase Chronic Myeloid Leukemia 1.00 11/25/2025 - 12:00am to 05/17/2026 - 12:00am
Optimizing First-Line Therapy for Diffuse Large B-Cell Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Diagnosis and Management of Secondary Hemophagocytic Lymphohistiocytosis 0.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Novel Treatment Options for Hodgkin Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma 1.50 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm
Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma 0.75 12/01/2025 - 12:00am to 11/30/2026 - 11:59pm

Pages